VAPO vs. AVGR, TMDIF, VERO, VVOS, TNON, INBS, STSS, INVO, OSA, and QNRX
Should you be buying Vapotherm stock or one of its competitors? The main competitors of Vapotherm include Avinger (AVGR), Titan Medical (TMDIF), Venus Concept (VERO), Vivos Therapeutics (VVOS), Tenon Medical (TNON), Intelligent Bio Solutions (INBS), Sharps Technology (STSS), INVO Bioscience (INVO), ProSomnus (OSA), and Quoin Pharmaceuticals (QNRX). These companies are all part of the "medical" sector.
Avinger (NASDAQ:AVGR) and Vapotherm (NYSE:VAPO) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, dividends, community ranking, risk, profitability, valuation and earnings.
Avinger has a beta of 1.22, meaning that its share price is 22% more volatile than the S&P 500. Comparatively, Vapotherm has a beta of -1.05, meaning that its share price is 205% less volatile than the S&P 500.
Avinger currently has a consensus price target of $5.00, suggesting a potential upside of 66.67%. Given Vapotherm's higher possible upside, analysts clearly believe Avinger is more favorable than Vapotherm.
In the previous week, Avinger had 5 more articles in the media than Vapotherm. MarketBeat recorded 5 mentions for Avinger and 0 mentions for Vapotherm. Avinger's average media sentiment score of 0.00 beat Vapotherm's score of -0.41 indicating that Vapotherm is being referred to more favorably in the news media.
Avinger has higher earnings, but lower revenue than Vapotherm. Avinger is trading at a lower price-to-earnings ratio than Vapotherm, indicating that it is currently the more affordable of the two stocks.
18.3% of Avinger shares are held by institutional investors. Comparatively, 43.1% of Vapotherm shares are held by institutional investors. 11.4% of Avinger shares are held by insiders. Comparatively, 15.8% of Vapotherm shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Vapotherm has a net margin of -78.40% compared to Vapotherm's net margin of -251.78%.
Avinger received 305 more outperform votes than Vapotherm when rated by MarketBeat users. Likewise, 59.55% of users gave Avinger an outperform vote while only 53.99% of users gave Vapotherm an outperform vote.
Summary
Avinger and Vapotherm tied by winning 8 of the 16 factors compared between the two stocks.
Get Vapotherm News Delivered to You Automatically
Sign up to receive the latest news and ratings for VAPO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding VAPO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Vapotherm Competitors List
Related Companies and Tools
